Andlauer Healthcare Group's market cap is currently ―. The company's EPS TTM is $1.172; its P/E ratio is 26.21; and it has a dividend yield of 0.87%. Andlauer Healthcare Group is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	C$ 155.47M	C$ 170.35M	C$ 157.36M	C$ 164.77M	C$ 165.77M
Gross Profit	C$ -46.78M	C$ 156.75M	C$ 157.36M	C$ 53.56M	C$ 58.45M
EBIT	C$ -77.58M	C$ 22.81M	C$ 23.48M	C$ 24.31M	C$ 28.63M
EBITDA	C$ -60.20M	C$ 40.12M	C$ 40.36M	C$ 41.13M	C$ 45.15M
Net Income Common Stockholders	C$ -86.42M	C$ 15.34M	C$ 15.72M	C$ 16.53M	C$ 19.82M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 59.74M	C$ 68.28M	C$ 84.27M	C$ 74.40M	C$ 65.86M
Total Assets	C$ 682.43M	C$ 698.08M	C$ 709.18M	C$ 718.16M	C$ 712.46M
Total Debt	C$ 127.90M	C$ 129.52M	C$ 156.04M	C$ 159.11M	C$ 163.29M
Net Debt	C$ 68.16M	C$ 61.24M	C$ 71.78M	C$ 84.71M	C$ 97.43M
Total Liabilities	C$ 212.86M	C$ 224.16M	C$ 247.46M	C$ 263.97M	C$ 271.47M
Stockholders Equity	C$ 469.57M	C$ 473.92M	C$ 461.73M	C$ 454.19M	C$ 440.99M
Cash Flow	-
Free Cash Flow	C$ 17.22M	C$ 23.19M	C$ 21.10M	C$ 19.06M	C$ 25.82M
Operating Cash Flow	C$ 25.16M	C$ 28.63M	C$ 26.23M	C$ 24.40M	C$ 36.74M
Investing Cash Flow	C$ -7.94M	C$ -5.45M	C$ -5.12M	C$ -5.34M	C$ -10.93M
Financing Cash Flow	C$ -25.26M	C$ -39.66M	C$ -10.77M	C$ -10.49M	C$ -10.11M

Currency in CAD

Andlauer Healthcare Group Earnings and Revenue History

Income Statement >

Andlauer Healthcare Group Debt to Assets

Balance Sheet >

Andlauer Healthcare Group Cash Flow

Cash Flow >

Andlauer Healthcare Group Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing